Showing 1 - 2 results of 2 for search 'Mark A. Tomai', query time: 0.01s
Refine Results
-
1
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques by Mayuresh M. Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K. Singh, Fernando Varnador, Sandra J. Sivananthan, Robert Kinsey, William R. Lykins, Brynn M. Murphy, Andrew R. Martin, Mark A. Tomai, Soutik Ghosal, Corey Casper, Karl Pedersen, William A. Petri, Christopher B. Fox
Published 2024-12-01Get full text
Article -
2
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines,... by William R. Lykins, Jeroen Pollet, Jeroen Pollet, Jessica A. White, Brian Keegan, Brian Keegan, Leroy Versteeg, Leroy Versteeg, Ulrich Strych, Ulrich Strych, Wen-Hsiang Chen, Wen-Hsiang Chen, Raodoh Mohamath, Gabi Ramer-Denisoff, Sierra Reed, Christina Renshaw, Samuel Beaver, Alana Gerhardt, Emily A. Voigt, Mark A. Tomai, Robert Sitrin, Robert K. M. Choy, Frederick J. Cassels, Peter J. Hotez, Peter J. Hotez, Peter J. Hotez, Maria Elena Bottazzi, Maria Elena Bottazzi, Christopher B. Fox, Christopher B. Fox
Published 2024-12-01Get full text
Article